|
| 金陵药业(000919)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-02-17 | 192.00 | 0.38% | 47464.93 | 3648.67 | 50388.15 | 98.58% | 股权激励限售股份 | | 2025-02-04 | 29.44 | 0.06% | 47272.93 | 3840.67 | 50388.15 | 98.58% | 股权激励限售股份 | | 2024-10-22 | 8647.80 | 16.92% | 47243.49 | 3870.11 | 50388.15 | 98.58% | 定向增发机构配售股份 | | 2015-08-31 | 22794.38 | 45.23% | 50400.00 | 0.00 | 50400.00 | 100.00% | 股权分置限售流通 | | 2012-09-21 | 2006.19 | 3.98% | 27605.62 | 22794.38 | 50400.00 | 100.00% | 股权分置限售流通 | | 2010-06-25 | 2367.88 | 4.70% | 25599.43 | 24800.57 | 50400.00 | 100.00% | 股权分置限售流通 | | 2010-04-15 | 3791.55 | 7.52% | 23231.55 | 27168.45 | 50400.00 | 100.00% | 股权分置限售流通 | | 2008-08-17 | 330.50 | 0.66% | 19440.00 | 30960.00 | 50400.00 | 100.00% | 股权分置股东增持股份上市 |
|